Elucidating the anti-inflammatory material basis of the Tibetan medicine Tiebangchui by integrating UPLC-Q-Orbitrap MS, serum pharmacochemistry, and a zebrafish model

Authors:

Abstract
No abstract available
Funding Information
  • Key Technologies Research and Development Program (2023YFC3504403)
  • Key Technologies Research and Development Program (2023YFC3504400)
  • Key Technologies Research and Development Program (2023YFC3504402)
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China (82204765)

This publication has 30 references indexed in Scilit: